HEART FAILURE WITH VOLUME OVERLOAD

Clinical trials for HEART FAILURE WITH VOLUME OVERLOAD explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE WITH VOLUME OVERLOAD trials appear

Sign up with your email to follow new studies for HEART FAILURE WITH VOLUME OVERLOAD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First human test for new heart failure fluid drug

Disease control Completed

This early-stage study tested the safety and effects of a new injectable drug, HRS-9057, in people with heart failure who had too much fluid in their bodies despite taking water pills. It involved 25 participants who received either the new injection or a standard pill (tolvaptan…

Matched conditions: HEART FAILURE WITH VOLUME OVERLOAD

Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

HEART FAILURE WITH VOLUME OVERLOAD

Get alerted when new HEART FAILURE WITH VOLUME OVERLOAD trials appear

First human test for new heart failure fluid drug